![ASAI - Sendas Distribuidora S.A. ADR - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=ASAI&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 2.38B | EPS (ttm) | 0.52 |
P/E | 16.88 | EPS this Y | 6.49% |
Forward P/E | 9.52 | EPS next Y | 68.58% |
PEG | 3.80 | EPS past 5Y | -20.91% |
P/S | 0.17 | EPS next 5Y | 4.44% |
P/B | 2.54 | EPS Q/Q | -12.70% |
Dividend | 0.97% | Sales Q/Q | 19.63% |
Insider Own | - | Inst Own | 9.54% |
Insider Trans | - | Inst Trans | -13.34% |
Short Float | - | Earnings | Apr 24/a |
Analyst Recom | 1.00 | Target Price | 15.06 |
Avg Volume | 267.47K | 52W Range | 8.63 - 15.25 |
|
|
|
Sendas Distribuidora SA engages in the retail and wholesale of food and other products through its stores. It operates through the Cash and Carry, and Exito Group segment. The Cash and Carry segment includes its business under the Assai brand. The Exito Group segment consists of its businesses in Columbia, Argentina, and Uruguay under the Exito, Surtimax, Super Inter, and Carulla brands. The company was founded by Arthur Antonio Sendas in 1974 and is headquartered in Sao Paulo, Brazil. |
|
![](gfx/nic2x2.gif) |
![OMIC - Singular Genomics Systems Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=OMIC&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 19.50M | EPS (ttm) | -39.39 |
P/E | - | EPS this Y | 8.54% |
Forward P/E | - | EPS next Y | 11.13% |
PEG | - | EPS past 5Y | -64.52% |
P/S | 7.83 | EPS next 5Y | 11.10% |
P/B | 0.12 | EPS Q/Q | -3.02% |
Dividend | - | Sales Q/Q | -48.78% |
Insider Own | 42.70% | Inst Own | 25.74% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.87% | Earnings | May 14/a |
Analyst Recom | 2.00 | Target Price | 6.50 |
Avg Volume | 5.91K | 52W Range | 7.50 - 27.60 |
|
|
|
Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. It develops two integrated solutions: G4 Instrument and PX Instrument. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Spaventa Andrew | Chief Executive Officer | Nov 17 '23 | Buy | 0.42 | 75,000 | 31,755 | 4,061,206 | Nov 20 04:31 PM | Glezer Eli N. | Chief Scientific Officer | Nov 16 '23 | Buy | 0.43 | 200,000 | 85,640 | 4,570,000 | Nov 20 04:30 PM | Spaventa Andrew | Chief Executive Officer | Nov 16 '23 | Buy | 0.41 | 43,468 | 17,857 | 3,986,206 | Nov 20 04:31 PM | Kamdar Kim P. | Director | Aug 15 '23 | Sale | 0.53 | 200,000 | 106,960 | 3,763,985 | Aug 15 07:17 PM | Kamdar Kim P. | Director | Aug 14 '23 | Sale | 0.57 | 77,991 | 44,424 | 3,963,985 | Aug 15 07:17 PM |
|
|
![](gfx/nic2x2.gif) |
![GPAK - Gamer Pakistan Inc. - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=GPAK&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 4.58M | EPS (ttm) | -0.00 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 337.55 | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | 24.22% | Inst Own | 0.53% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.01% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 1.04M | 52W Range | 0.15 - 4.39 |
|
|
|
Gamer Pakistan, Inc. is a development-stage interactive esports event promotion and product marketing company. The firm conducts its operations in Pakistan through K2 Gamer (PVT) Ltd. and Elite Sports Pakistan Pvt. Ltd. It focuses on creating college, inter-university and professional esports events for both men's and women's teams, especially esports opportunities with colleges and universities in Pakistan. The firm intends to expand its esports offerings, expand to other markets and consider live sports. The company was founded on November 23, 2021 and is headquartered in Henderson, NV. |
|
| ![](gfx/nic2x2.gif) |
![LVS - Las Vegas Sands Corp - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=LVS&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 29.19B | EPS (ttm) | 2.13 |
P/E | 18.38 | EPS this Y | 33.62% |
Forward P/E | 13.54 | EPS next Y | 14.60% |
PEG | - | EPS past 5Y | -12.26% |
P/S | 2.55 | EPS next 5Y | -1.75% |
P/B | 7.38 | EPS Q/Q | 17.11% |
Dividend | 2.04% | Sales Q/Q | 8.62% |
Insider Own | 46.81% | Inst Own | 47.13% |
Insider Trans | -0.03% | Inst Trans | 0.35% |
Short Float | 2.76% | Earnings | Jul 24/a |
Analyst Recom | 1.29 | Target Price | 56.25 |
Avg Volume | 6.10M | 52W Range | 39.25 - 60.47 |
|
|
|
Las Vegas Sands Corp. engages in the development of destination properties. It operates through the Macao and Singapore geographical segments. The Macao segment handles the operations of The Venetian Macao, The Londoner Macao, The Parisian Macao, The Plaza Macao and Four Seasons Macao, and Sands Macao. The Singapore segment includes the Marina Bay Sands. The company was founded by Sheldon Gary Adelson in August 2004 and is headquartered in Las Vegas, NV. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Hudson D. Zachary | EVP and Global General Counsel | Apr 26 '24 | Option Exercise | 0.00 | 7,822 | 0 | 28,863 | Apr 30 06:13 PM | Hyzak Randy | EVP & CFO | Apr 26 '24 | Option Exercise | 0.00 | 8,534 | 0 | 33,652 | Apr 30 06:34 PM | Dumont Patrick | President & COO | Apr 26 '24 | Option Exercise | 0.00 | 28,447 | 0 | 380,452 | Apr 30 06:35 PM | Goldstein Robert G | Chairman & CEO | Apr 26 '24 | Option Exercise | 0.00 | 51,000 | 0 | 51,000 | Apr 30 06:45 PM | Goldstein Robert G | Chairman & CEO | Mar 15 '24 | Sale | 52.06 | 100,000 | 5,206,000 | 172,801 | Mar 19 07:31 PM |
|
|
![](gfx/nic2x2.gif) |
![LSH - Lakeside Holding Ltd. - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=LSH&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 18.60M | EPS (ttm) | 0.03 |
P/E | 71.47 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 1.06 | EPS next 5Y | - |
P/B | 29.14 | EPS Q/Q | -89.31% |
Dividend | - | Sales Q/Q | 35.13% |
Insider Own | - | Inst Own | - |
Insider Trans | - | Inst Trans | - |
Short Float | 0.61% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 96.37K | 52W Range | 2.41 - 5.37 |
|
|
|
Lakeside Holding Ltd. provides cross-border supply chain solutions. Its services include customs clearance services, warehousing and distribution services, cross-border freight consolidation and forwarding services, and US domestic ground transportation services. The company was founded by Henry Liu and Shuai Li in February 2018 and is headquartered in Itasca, IL. |
|
| ![](gfx/nic2x2.gif) |
![STLA - Stellantis N.V - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=STLA&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 49.85B | EPS (ttm) | 6.40 |
P/E | 2.76 | EPS this Y | -27.72% |
Forward P/E | 3.31 | EPS next Y | 6.81% |
PEG | - | EPS past 5Y | 18.67% |
P/S | 0.24 | EPS next 5Y | -6.45% |
P/B | 0.59 | EPS Q/Q | 6.13% |
Dividend | 8.30% | Sales Q/Q | 3.85% |
Insider Own | 30.85% | Inst Own | 32.78% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 1.22% | Earnings | Jul 25/b |
Analyst Recom | 1.89 | Target Price | 25.32 |
Avg Volume | 6.61M | 52W Range | 17.57 - 29.51 |
|
|
|
Stellantis NV engages in the design, manufacture, distribution, and sale of vehicles. It offers its products under the Abarth, Alfa Romeo, Chrysler, Citroen, Dodge, DS, Fiat, Fiat Professional, Jeep, Lancia, Opel, Peugeot, Ram, and Vauxhall brands. The company was founded on April 01, 2014 and is headquartered in Hoofddorp, the Netherlands. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Stellantis N.V. | 10% Owner | Jul 01 '24 | Buy | 3.16 | 17,401,153 | 54,999,824 | 56,752,873 | Jul 03 04:20 PM | Stellantis N.V. | 10% Owner | Mar 15 '24 | Buy | 5.19 | 750,000 | 3,894,053 | 39,351,720 | Mar 18 04:17 PM | Stellantis N.V. | 10% Owner | Mar 14 '24 | Buy | 4.99 | 750,000 | 3,743,249 | 38,601,720 | Mar 18 04:17 PM | Stellantis N.V. | 10% Owner | Mar 13 '24 | Buy | 5.36 | 800,000 | 4,286,000 | 37,851,720 | Mar 14 04:45 PM | Stellantis N.V. | 10% Owner | Mar 12 '24 | Buy | 4.98 | 800,000 | 3,984,951 | 37,051,720 | Mar 14 04:45 PM |
|
|
![](gfx/nic2x2.gif) |
![JAGX - Jaguar Health Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=JAGX&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 6.13M | EPS (ttm) | -74.86 |
P/E | - | EPS this Y | 99.36% |
Forward P/E | - | EPS next Y | -265.77% |
PEG | - | EPS past 5Y | 86.10% |
P/S | 0.60 | EPS next 5Y | 40.00% |
P/B | 0.49 | EPS Q/Q | 97.57% |
Dividend | - | Sales Q/Q | 19.22% |
Insider Own | 12.63% | Inst Own | 1.99% |
Insider Trans | 0.00% | Inst Trans | -58.62% |
Short Float | 6.83% | Earnings | May 14/b |
Analyst Recom | 1.00 | Target Price | 14.50 |
Avg Volume | 1.09M | 52W Range | 1.26 - 39.60 |
|
|
|
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. It operates through the Human Health and Animal Health segments. The Human Health segment is involved in manufacturing human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment includes commercializing prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA. |
|
| ![](gfx/nic2x2.gif) |
![FIVE - Five Below Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=FIVE&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 3.96B | EPS (ttm) | 5.32 |
P/E | 13.52 | EPS this Y | -11.11% |
Forward P/E | 13.32 | EPS next Y | 12.34% |
PEG | 1.13 | EPS past 5Y | 15.26% |
P/S | 1.09 | EPS next 5Y | 12.01% |
P/B | 2.50 | EPS Q/Q | -15.24% |
Dividend | - | Sales Q/Q | 11.79% |
Insider Own | 2.71% | Inst Own | 107.50% |
Insider Trans | 0.00% | Inst Trans | 0.51% |
Short Float | 8.06% | Earnings | Jun 05/a |
Analyst Recom | 2.28 | Target Price | 105.38 |
Avg Volume | 1.78M | 52W Range | 71.56 - 216.18 |
|
|
|
Five Below, Inc. operates as a specialty value retailer. It operates through the following segments: Leisure, Fashion and Home, and Party and Snack. The Leisure segment includes items such as sporting goods, games, toys, tech, books, electronic accessories, and arts and crafts. The Fashion and Home segment consists of personal accessories, "attitude" t-shirts, beauty offerings, home goods, and storage options. The Party and Snack segment offers party and seasonal goods, greeting cards, candy, and other snacks and beverages. The company was founded by David Schlessinger and Thomas G. Vellios in January 2002 and is headquartered in Philadelphia, PA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Vellios Thomas | Director | Jan 19 '24 | Sale | 185.82 | 10,000 | 1,858,225 | 333,697 | Jan 23 04:09 PM | Anderson Joel D | President & CEO | Sep 08 '23 | Buy | 161.50 | 3,100 | 500,650 | 99,656 | Sep 12 04:46 PM |
|
|
![](gfx/nic2x2.gif) |
![DSX - Diana Shipping Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=DSX&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 323.66M | EPS (ttm) | 0.23 |
P/E | 11.85 | EPS this Y | -25.70% |
Forward P/E | 3.36 | EPS next Y | 196.30% |
PEG | 2.37 | EPS past 5Y | 32.94% |
P/S | 1.31 | EPS next 5Y | 5.00% |
P/B | 0.65 | EPS Q/Q | -97.45% |
Dividend | 11.15% | Sales Q/Q | -20.64% |
Insider Own | 38.86% | Inst Own | 12.93% |
Insider Trans | 0.00% | Inst Trans | -13.79% |
Short Float | 1.80% | Earnings | Jul 31/b |
Analyst Recom | 1.67 | Target Price | 3.70 |
Avg Volume | 671.33K | 52W Range | 2.66 - 3.81 |
|
|
|
Diana Shipping, Inc. operates as a holding company, which engages in the provision of shipping transportation services through the ownership and operation of dry bulk vessels. Its vessels are being employed primarily on medium to long-term time charters and transport a range of dry bulk cargoes, including such commodities as iron ore, coal, grain, and other materials along worldwide shipping routes. The company was founded on March 8, 1999 and is headquartered in Athens, Greece. |
|
![](gfx/nic2x2.gif) |
![PRPH - ProPhase Labs Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=PRPH&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 61.44M | EPS (ttm) | -1.34 |
P/E | - | EPS this Y | 37.76% |
Forward P/E | 6.71 | EPS next Y | 178.69% |
PEG | - | EPS past 5Y | -47.90% |
P/S | 2.14 | EPS next 5Y | - |
P/B | 1.30 | EPS Q/Q | -1158.54% |
Dividend | - | Sales Q/Q | -81.17% |
Insider Own | 17.47% | Inst Own | 8.92% |
Insider Trans | 0.00% | Inst Trans | 28.09% |
Short Float | 2.01% | Earnings | May 09/b |
Analyst Recom | 1.00 | Target Price | 16.00 |
Avg Volume | 37.17K | 52W Range | 3.03 - 7.55 |
|
|
Jul-11-24 08:00AM
|
ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress
(GlobeNewswire) |
May-16-24 08:00AM
|
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)
(GlobeNewswire) |
May-10-24 04:19PM
|
ProPhase Labs, Inc. (NASDAQ:PRPH) Q1 2024 Earnings Call Transcript
(Insider Monkey) |
May-09-24 03:40PM
|
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - Updated
(GlobeNewswire) -8.72% |
08:00AM
|
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.
(GlobeNewswire) |
May-02-24 10:01AM
|
ProPhase Labs, Inc. (PRPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
(Zacks) |
08:00AM
|
PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9
(GlobeNewswire) |
Apr-29-24 09:00AM
|
Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV
(ACCESSWIRE) |
Apr-25-24 08:00AM
|
ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
(GlobeNewswire) |
Apr-23-24 09:00AM
|
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)
(GlobeNewswire) +5.31% |
|
ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. It operates through the Diagnostic Services and Consumer Products segment. The Diagnostic Services segment includes COVID-19 and other diagnostic testing services. The Consumer Products segment consists of the manufacturing, retail customers, and personal genomics products and services. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Garden City, NY. |
|
|